Limaprost ( DrugBank: Limaprost )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
70広範脊柱管狭窄症3

70. 広範脊柱管狭窄症


臨床試験数 : 95 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000012918
2014/04/0101/03/2014Long-term efficacy and safety of Limaprost for the treatment of Lumbar Spinal StenosisLong-term efficacy and safety of Limaprost for the treatment of Lumbar Spinal Stenosis - Long-term efficacy of Limaprost for LSS Lumbar Spinal StenosisLimaprost alfadex(15 micro g/day), 1yrs.Kansai LSS ForumNULLPending50years-old80years-oldMale and Female300Not selectedJapan
2NCT01888536
(ClinicalTrials.gov)
February 201325/6/2013A Study to Evaluate Efficacy of ?Opast Tablet?for Neurologic Claudication in Patients With Lumbar Spinal StenosisA Randomized, Double-Blind, Comparative, Multi-Center, Phase ? Clinical Trial to Evaluate Efficacy of ?Opast Tablet?for Neurologic Claudication in Patients With Lumbar Spinal StenosisNeurologic Claudication in Patients With Lumbar Spinal StenosisDrug: Limaprost;Drug: Pregabalin;Drug: Placebo(for Pregabalin);Drug: Placebo(for Limaprost)Yungjin Pharm. Co., Ltd.NULLCompleted20 Years75 YearsBoth182Phase 4Korea, Republic of
3JPRN-UMIN000004825
2011/01/0106/01/2011A randomized comparative study of Celecoxib and Limaprost alfadex on the patients with lumber spinal stenosis for the effectiveness for symptoms and QOLA randomized comparative study of Celecoxib and Limaprost alfadex on the patients with lumber spinal stenosis for the effectiveness for symptoms and QOL - A randomized comparative study of medications for patients with lumber spinal stenosis Lumbar spinal stenosis15ug/day Limaprost arfadex for 8 weeks
200mg/day Celecoxib for 8 weeks
University of Tsukuba, Course of life-style related disorders donated by JA Ibaraki Public Welfare FederationMito Kyodo HospitalComplete: follow-up complete40years-old85years-oldMale and Female134Phase 3Japan